Oral cephalosporins: newer agents and their place in therapy.

Author: ShaughnessyA F, ThompsonE M

Paper Details 
Original Abstract of the Article :
Cefprozil, cefpodoxime and loracarbef are three new oral cephalosporins available for the treatment of common community-acquired infections. They share with other cephalosporins a low incidence of side effects and offer the convenience of twice-daily dosing. These agents can be considered effective,...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/8042575

データ提供:米国国立医学図書館(NLM)

New Frontiers in Oral Cephalosporin Therapy: A Desert Oasis of Options

Bacterial infections, a constant threat in the world, require effective treatments. This research, like a traveler discovering a new oasis, explores the potential of three newer oral cephalosporins: cefprozil, cefpodoxime, and loracarbef.

Effective and Convenient: A Winning Combination

The authors point out the effectiveness and convenience of these new cephalosporins, highlighting their low side effects and twice-daily dosing schedule. These drugs are like a reliable camel, offering a dependable solution for a variety of common infections.

Alternative Treatment Options: A Broader Landscape

The study also suggests that cefpodoxime, in particular, might offer a viable alternative to intramuscular antibiotics for treating uncomplicated gonorrhea.

Dr. Camel's Conclusion

This research provides valuable insights into the potential of newer oral cephalosporins for treating a range of common infections. Their effectiveness, convenience, and low side effect profile make them a valuable addition to the medical arsenal, offering clinicians more options to combat bacterial infections effectively.

Date :
  1. Date Completed 1994-08-24
  2. Date Revised 2006-11-15
Further Info :

Pubmed ID

8042575

DOI: Digital Object Identifier

8042575

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.